Literature DB >> 3468291

Phagocytic capacity of normal and malignant rat glial cells in culture.

R Bjerknes, R Bjerkvig, O D Laerum.   

Abstract

The phagocytic capacity of 4 continuous rat glioma cell lines (BT2C, BT4Cn, BT5c, and 9L) and normal BD IX fetal rat glial cells in culture has been studied. This was done by flow cytometric measurements of single cells from monolayer cultures having ingested fluorescent bacteria, zymosan particles, red blood cells, or fragments of normal glial cells. In addition, phagocytosis was studied in a three-dimensional culture system. The BT4Cn, BT5C, and 9L cell lines were tumorigenic and invasive both in vivo and in organ culture in vitro. In contrast, BT2C has shown variable tumorigenicity and does not seem to be invasive. The phagocytic capacity of the cell lines was compared to their destructive properties during invasion. Depending on the particle type, 30-40% of the normal glial cells were phagocytic. The fractions of phagocytic glioma cells were dependent on the particle type and the prey load. Of the invasive cell lines, BT5C showed high phagocytic activity both in monolayer and three-dimensional cultures. Two of the invasive cell lines (BT5C and 9L) had about the same fraction of phagocytic cells as normal glial cells. These 2 cell lines showed highly destructive growth during invasion. In contrast, the third invasive cell line (BT4Cn) had almost no phagocytic cells. The BT4Cn cells showed single-cell invasion with little destruction of target tissue. The noninvasive cell line (BT2C) showed low phagocytic activity, and almost no destruction was observed in the border zone between tumor cells and normal tissue. Phagocytosis seems to be an inherent property of both normal and malignant glial cells, although the fraction of phagocytic cells varies from one cell line to another. In organ culture high phagocytic capacity of invasive glioma cells seems to be related to destructive activity on the normal brain tissue during invasion.

Entities:  

Mesh:

Year:  1987        PMID: 3468291

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BD IX rats.

Authors:  O Mella; R Bjerkvig; B C Schem; O Dahl; O D Laerum
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

Review 3.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

4.  Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.

Authors:  Michael Neumann; Ulrike Kunz; Heiner Lehmann; Detlef Gabel
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

Review 5.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 6.  Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?

Authors:  Leanne C Huysentruyt; Zeynep Akgoc; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2011-09-22       Impact factor: 4.146

7.  Microglia immunophenotyping in gliomas.

Authors:  Laura Annovazzi; Marta Mellai; Enrica Bovio; Samanta Mazzetti; Bianca Pollo; Davide Schiffer
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.